303 related articles for article (PubMed ID: 36815224)
1. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
4. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
5. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
Hou L; Li S; Li S; Wang R; Zhao M; Liu X
J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
[TBL] [Abstract][Full Text] [Related]
6. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
[TBL] [Abstract][Full Text] [Related]
7. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation modification of FTO facilitates oxidative damage response of arsenic by IGF2BP3 in an m6A-dependent manner.
Zhang H; Chen Q; Han H; Guo C; Jiang X; Xia Y; Zhang Y; Zhou L; Zhang J; Tian X; Mao L; Qiu J; Zou Z; Chen C
J Hazard Mater; 2024 Jul; 472():134440. PubMed ID: 38723480
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
[TBL] [Abstract][Full Text] [Related]
13. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Zhang W; Wang L; Zhang P; Zhang Q
Medicine (Baltimore); 2021 May; 100(20):e25952. PubMed ID: 34011074
[TBL] [Abstract][Full Text] [Related]
14. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
15. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
[TBL] [Abstract][Full Text] [Related]
16. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
Han X; Liu J; Cheng G; Cui S
Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
[TBL] [Abstract][Full Text] [Related]
17. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
18. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
[TBL] [Abstract][Full Text] [Related]
20. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
Yin Z; Guo X; Liang X; Wang Z
Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
